Product
Sham procedure
2 clinical trials
2 indications
Indication
Central Retinal Artery OcclusionClinical trial
A Phase 1/2 Two-Stage Dose Escalation and Randomized Parallel-Group Study to Evaluate the Safety, Preliminary Treatment Effects, and Durability of AR-14034 Sustained Release Implant Compared to Intravitreal Anti-Vascular Endothelial Growth Factor Treatment in Participants With Neovascular Age-Related Macular DegenerationStatus: Recruiting, Estimated PCD: 2027-02-01
Clinical trial
A Phase 2, Double-masked, Randomized, Sham-controlled, Multiple-dose Study of the Efficacy and Safety of Intravitreal KUS121 in the Treatment of Non-Arteritic Central Retinal Artery Occlusion (CRAO)Status: Recruiting, Estimated PCD: 2024-12-01